RBS Capped Callable Leveraged Steepener Notes CUSIP: 78009PBK6

Did You Invest in the Royal Bank of Scotland’s Capped Callable Leveraged Steepener Notes Linked to the Difference between CMS30 and CMS2 due August 2031 (CUSIP: 78009PBK6)?

According to RBS’s prospectus on CUSIP: 78009PBK6:

These securities are designed for investors who place a priority on the preservation of principal at maturity, while potentially offering better returns than traditional fixed income investments. These securities tend to have a longer term than securities that do not offer protection, and principal invested is not protected prior to maturity.

Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):

If you bought the structured product known as Royal Bank of Scotland’s Capped Callable Leveraged Steepener Notes Linked to the Difference between CMS30 and CMS2 due August 2031 CUSIP: 78009PBK6, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.

Image credit: Elliott Brown via Flickr